WSC 2025, Barcelona - EVER Symposium

In October 2025 the 17^th World Stroke Congress (WSC) took place in Barcelona, Spain. This event brought together over 2700 leading clinicians and researchers from around the globe to discuss the latest developments in stroke treatment and neurorehabilitation.

The EVER Pharma symposium was moderated by Dr. Jennifer Manzano (Philippines). It provided insights from two experts, Prof. Sławomir Michalak (Poland) and Dr. Daniel Šaňák (Czech Republic).

• Prof. Sławomir Michalak presented new research on blood–brain barrier integrity and endothelial protection during the hyperacute phase of stroke, highlighting the role of Cerebrolysin^® in stabilizing tight junction proteins and reducing the risk of hemorrhagic transformation when used alongside reperfusion therapy.
  
• Dr. Daniel Šaňák presented results from the recently published CREGS study, a large international, real-world investigation evaluating the effectiveness and safety of Cerebrolysin^® in patients with moderate acute ischemic stroke (AIS). His presentation emphasized the clinical value of adjunctive cerebroprotective therapy in improving functional recovery and extending benefits beyond reperfusion.

To get a more detailed insight, please read the report and watch the videos here.